Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 6/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | TYR | P14679 | 4/20 | 0.52 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4635939 | 0.91 | AKR1B1 (0.53) | SLC28A3AKR1B1DPP4TYRSLC5A1 | |
| SCHEMBL4635920 | 0.87 | SLC28A3 (0.58) | SLC28A3AKR1B1DPP4TYRHPGD | |
| SCHEMBL4636284 | 0.86 | NPC1 (0.64) | SLC28A3AKR1B1DPP4TYRKDM4E | |
| SCHEMBL4635348 | 0.85 | SLC28A3 (0.56) | SLC28A3AKR1B1DPP4TYRSLC5A1 | |
| SCHEMBL4635767 | 0.83 | TYR (0.59) | SLC28A3AKR1B1DPP4TYRSLC5A1 | |
| SCHEMBL4636214 | 0.83 | SLC28A3 (0.56) | SLC28A3AKR1B1DPP4TYRSLC5A1 | |
| SCHEMBL7780208 | 0.83 | SLC28A3 (0.50) | SLC28A3AKR1B1DPP4TYRSLC5A1 | |
| SCHEMBL941797 | 0.82 | SLC28A3 (0.58) | SLC28A3TYRSLC5A1SLC5A2 | |
| SCHEMBL7781036 | 0.82 | SLC28A3 (0.49) | SLC28A3AKR1B1DPP4TYRSLC5A1 | |
| SCHEMBL941369 | 0.81 | NPC1 (0.56) | AKR1B1DPP4TYRNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1932514-B1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | EZAKI GLICO CO (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | EZAKI GLICO CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | EZAKI GLICO CO., LTD. (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1932514-A1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | Ezaki Glico Co., Ltd. (JP) | 2008-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | SI, CUTA, CD44 | SLC28A3 1164/4885AKR1B1 3154/4885DPP4 3179/4885 |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | CUTA, SI, CD44 | SLC28A3 977/4885AKR1B1 3102/4885DPP4 3158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.